Back
Oak Valley Bancorp 10K Form
Buy
57
OVLY
Oak Valley Bancorp
Last Price:
$30.13
Seasonality Move:
1.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-14 | 10Q | OVLY/Oak Valley Bancorp Quarterly |
| 2023-11-14 | 10Q | OVLY/Oak Valley Bancorp Quarterly |
| 2023-08-14 | 10Q | OVLY/Oak Valley Bancorp Quarterly |
| 2023-05-15 | 10Q | OVLY/Oak Valley Bancorp Quarterly |
| 2022-11-14 | 10Q | OVLY/Oak Valley Bancorp Quarterly |
| 2022-08-12 | 10Q | OVLY/Oak Valley Bancorp Quarterly |
Receive OVLY News And Ratings
See the #1 stock for the next 7 days that we like better than OVLY
OVLY Financial Statistics
Sales & Book Value
| Annual Sales: | $89.5M |
|---|---|
| Cash Flow: | $6.3M |
| Price / Cash Flow: | 12.13 |
| Annual Sales: | $23.63 |
| Price / Book: | 1.27 |
Profitability
| EPS (TTM): | 2.84660 |
|---|---|
| Net Income (TTM): | $23.6M |
| Gross Margin: | $0 |
| Return on Equity: | 12.59% |
| Return on Assets: | 1.22% |
Oak Valley Bancorp Earnings Forecast
Key Oak Valley Bancorp Financial Ratios
-
The Gross Profit Margin over the past 19 years for OVLY is 0.00%.
-
The Selling, General & Administrative Expenses for OVLY have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of OVLY is 27.87% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 18 years.
Oak Valley Bancorp Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Banks |
| Sector: | Financials |
| Current Symbol: | OVLY |
| CUSIP: | 671807 |
| Website: | ovcb.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.15 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.94 |
|---|---|
| Forward P/E Ratio: | 0 |
OVLY Technical Analysis vs Fundamental Analysis
Buy
57
Oak Valley Bancorp (OVLY)
is a Buy
Is Oak Valley Bancorp a Buy or a Sell?
-
Oak Valley Bancorp stock is rated a BuyThe current Oak Valley Bancorp [OVLY] share price is $30.04. The Score for OVLY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.